PPARalpha agonist 5 is an orally available, selective partial agonist of PPARalpha (EC50: 3 nM). PPARalpha agonist 5 reduces lipid accumulation and upregulates key PPARalpha target genes, exerting anti-fatty liver effects. PPARalpha agonist 5 also exhibits significant hypolipidemic and hypoglycemic effects through partial PPARgamma agonist activity and mild inhibition of protein tyrosine phosphatase 1B (PTP1B) (IC50: 79.1 µM). PPARalpha agonist 5 has a good safety profile and can be used in the study of type 2 diabetes with dyslipidemia[1].
Molecular Weight:
368.42
Formula:
C25H20O3
Target:
Phosphatase,PPAR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
